EBEliana Nogueira Castro de Barros

Eliana Nogueira Castro de Barros

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Eliana Nogueira Castro de Barros has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence of SARS-CoV-2 Infection Among Vulnerable Populations Relying on Public Health Services: Findings from the AVISA Study in Brazil

    by Eliana Nogueira Castro de Barros, Manuela de Almeida Roediger, Ricardo Queiroz Gurgel, Marco Antonio de Oliveira, Victor Santana Santos, Lorena Guadalupe Barberia

    Background: Understanding SARS-CoV-2 seroprevalence among vulnerable populations is crucial, especially in countries with universal but resource-constrained healthcare systems, such as Brazil. Methods: This was a cross-sectional, population-based household survey within the AVISA study, which aimed to assess seroprevalence among households enrolled in the Family Health Program (ESF). Two serological assays (rapid test and ECLIA) were used to detect anti-SARS-CoV-2 antibodies. Descriptive statistics were calculated and survey-adjusted Poisson regression models with robust variance were estimated, yielding prevalence ratios (PRs) and 95% confidence intervals (CIs). Results: The overall weighted seroprevalence was 35.66% (95% CI: 30.55-40.77) in 2,986 participants. Compared with individuals in the Southeast region, participants in the Northeast and North regions had a 1.48- and 1.38-times higher prevalence of SARS-CoV-2 testing positivity, respectively. Relative to individuals who self-identified as having Black or Brown skin color using IBGE-defined categories, White had a 22% lower prevalence of seropositivity (PR = 0.78, 95% CI 0.63-0.97). Compared to those living in households with four to five family members, individuals living in households with six or more family members had a higher prevalence of seropositivity (PR = 1.34, 95% CI 1.05-1.71). Individuals in the lowest per capita household income quintile were more likely to have SARS-CoV-2 infection (PR = 1.89, 95% CI 1.21-2.95) than those in the highest. Conclusion: This study is the first to assess SARS-CoV-2 seroprevalence among ESF participants, a socioeconomically vulnerable population, served by the primary care public health system. Lower socioeconomic status was associated with higher seroprevalence.


  • Open Access

    Panorama da infecção pelo SARS-COV-2 no Centro de Progressão Penitenciária do Butantan

    by Soraya Gomes de Amorim Andrade, Fernando Moreira Andrade, Anderson da Silva, Maria Regina Alves Cardoso, Guilherme Rodrigues Ferraz, Eliana Nogueira Castro de Barros, Patrícia Emilia Braga, Milena Martello Cristófalo, Júlia Rabello Guerra Vieira, Carolina de Souza Lopes, et al.

    OBJECTIVE: To estimate the prevalence of exposure to the SARS-CoV-2 virus among individuals living in restricted freedom. METHODS: A seroprevalence survey was carried out with the population of the female penitentiary of the Centro de Progressão Penitenciária (CPP) in Butantan (municipality of São Paulo), between June 24 and August 20, 2020. During this period, according to the Secretariat of Penitentiary Administration (SAP), the positivity of rapid tests among inmates ranged from 65% to 78%. The evaluation method used in the study was the “One Step COVID-19” rapid test (chromatography), from the company Wondfo, also using the RT-PCR method in symptomatic participants to confirm the viral condition. The study population consisted of 879 female inmates and 170 employees of the institution. RESULTS: The prevalence of total antibodies (IgG/IgM) against the SARS-CoV-2 virus in the total population of 1049 study participants was 6.1%; among the population of 879 inmates, a prevalence of 5.8% was observed, and among the institution’s employees, 7.5%. CONCLUSIONS: The prevalence of covid-19 at the Butantan CPP was low, which is due to the implementation of simple prevention measures at the institution, such as the use of masks (with appropriate changes), emphasis on hygiene, hand washing and social distancing, in addition to other strategies, such as suspending inmates’ visits from relatives and friends and cutting back on elective medical appointments and outside work.


  • Open Access

    The emergence of novel SARS-CoV-2 variant P.1 in Amazonas (Brazil) was temporally associated with a change in the age and sex profile of COVID-19 mortality: A population based ecological study

    by André Ricardo Ribas Freitas, Otto Albuquerque Beckedorff, Luciano Pamplona de Góes Cavalcanti, Andre M. Siqueira, Daniel Barros de Castro, Cristiano Fernandes da Costa, Daniele Rocha Queiróz Lemos, Eliana N.C. Barros


  • Open Access

    The increase in the risk of severity and fatality rate of covid-19 in southern Brazil after the emergence of the Variant of Concern (VOC) SARS-CoV-2 P.1 was greater among young adults without pre-existing risk conditions

    by André Ricardo Ribas Freitas, Daniele Rocha Queiróz Lemos, Otto Albuquerque Beckedorff, Luciano Pamplona de Góes Cavalcanti, Andre M Siqueira, Regiane Cristina Santos de Mello, Eliana N C Barros

    Background: The SARS-CoV-2 P.1 variant has been considered as “variant of concern (VOC)” since the end of 2020 when it was firstly identified in the Brazilian state of Amazonas and from there spread to other regions of Brazil. This variant was associated with an increase in transmissibility and worsening of the epidemiological situation in the places where it was detected. The aim of this study was to analyze the severity profile of covid-19 cases in the Rio Grande do Sul state, southern region of Brazil, before and after the emergence of the P.1 variant, considering also the context of the hospitals overload and the collapse of health services. Methods: We analyzed data from the Influenza Epidemiological Surveillance Information System, SIVEP-Gripe (Sistema de Informação de Vigilância Epidemiológica da Gripe) and compare two epidemiological periods: the “first wave” comprised by cases occurred during November and December 2020 (EW 45 to 53) and the “second wave” with cases occurred in February 2021 (EW 5 to 8), considering that in this month there was a predominance of the new variant P.1. We calculated the proportion of severe forms among the total cases of covid-19, the case fatality rates (CFR) and hospital case fatality rate (hCFR) over both waves time set using the date of onset of symptoms as a reference. We analyzed separately the patients without pre-existing conditions of risk, by age and sex. For comparison between periods, we calculated the Risk Ratio (RR) with their respective 95% confidence intervals and the p-values. Findings: We observed that in the second wave there were an increase in the proportion of severe cases and covid-19 deaths among younger age groups and patients without pre-existing conditions of risk. The proportion of people under the age of 60 among the cases that evolved to death raised from 18% (670 deaths) in November and December (1 st wave) to 28% (1370 deaths) in February (2 nd wave). A higher proportion of patients without pre-existing risk conditions was also observed among those who evolved to death due to covid-19 in the second wave (22%, 1,077 deaths) than in the first one (13%, 489 deaths). The CFR for covid-19 increased overall and in different age groups, in both sexes. The increase occurred in a greatest intensity in the population between 20 and 59 years old and among patients without pre-existing risk conditions. Female 20 to 39 years old, with no pre-existing risk conditions, were at risk of death 5.65 times higher in February (95%CI = 2.9 - 11.03; p <0.0001) and in the age group of 40 and 59 years old, this risk was 7.7 times higher (95%CI = 5.01-11.83; p <0.0001) comparing with November-December. Interpretation: Our findings showed an increase in the proportion of young people and people without previous illnesses among severe cases and deaths in the state of RS after the identification of the local transmission of variant P.1 in the state. There was also an increase in the proportion of severe cases and in the CFR, in almost all subgroups analyzed, this increase was heterogeneous in different age groups and sex. As far as we know, these are the first evidences that the P.1 variant can disproportionately increase the risk of severity and deaths among population without pre-existing diseases, suggesting related changes in pathogenicity and virulence profiles. New studies still need to be done to confirm and deepen these findings.


  • Open Access

    Epidemiology of pertussis among adolescents, adults, and older adults in selected countries of Latin American: a systematic review

    by Altacilio Nunes, Ariane Abreu, Bárbara Furtado, Anderson Soares da Silva, Eduardo B. Coelho, Eliana Nc de Barros

    We aimed to describe the impact of pertussis on adolescents, adults, and older adults over 2007–2018 in selected Latin American countries by reviewing the literature. We searched the Medline, Embase, Scopus, LILACS, Scielo, Google Scholar, CAPES Journals Web-portal, and Cochrane databases for observational epidemiological studies, clinical trials, and systematic reviews of primary studies. Data were extracted and analyzed for all individuals aged ≥10 years. Of 6,891 studies identified only 25 were eligible. Studies were conducted in Brazil (14), Argentina (4), Colombia (4), Mexico (2) and Chile (1). Epidemiological data among target population were limited. No studies clearly assessed the status of asymptomatic or oligosymptomatic B. pertussis carriers in these age groups. Among all pertussis cases identified, the percentage of patients ≥10 years-old ranged between 2.1% and 66.7% depending on country and sample characteristics. The definition of cases, diagnostic methods, and age groups were not consistent across studies.


  • Burden of herpes zoster among Brazilian adults – a hospital-based study

    by Ariane de Jesus Lopes de Abreu, Amanda Venys, Wilson Jacob, Thiago da Silva, Angela Henrique, Kusuma Gopala, Eliana Nogueira Castro de Barros

    OBJECTIVE: To describe the clinical features of herpes zoster in adult patients treated at a large tertiary care hospital in Brazil over a 5-year period. METHODS: The medical records of suspected herpes zoster cases (based on ICD-10 codes) were identified for full review. Convenience sampling was used to select the medical records from a tertiary hospital in São Paulo. We collected data about co-existing medical conditions, medication use, herpes zoster-related clinical features and outcomes, and healthcare resource utilization. RESULTS: A total of 249 individuals whose first episode of herpes zoster occurred between 2010 and 2014 were included. The mean patient age was 55 years (range 18–96), and the majority were women (63.05%) and aged ≥ 50 years (63.86%). Medical comorbidities were reported in 92.77%, including diabetes (19.68%) and HIV infection (7.63%). Current/recent use of immunosuppressive agents was reported in 31.73%. A total of 65.86% of the patients were hospitalized: 102 patients (40.96%) were admitted for herpes zoster management, while 62 (24.90%) were already receiving inpatient care. The mean hospital length of stay was 16.60 days. One-third (34.14%) were managed as outpatients. Postherpetic neuralgia was reported as a complication in 18.07%. CONCLUSIONS: This retrospective descriptive study found a high frequency of herpes zoster episodes in older adults with comorbidities who sought medical care at a tertiary hospital. These results also underscore the importance of understanding the epidemiology of this disease and developing control strategies for these at-risk populations in Brazil.


  • Open Access

    COVID-19 in long-term care facilities in Brazil: serological survey in a post-outbreak setting

    by Eliana Nogueira Castro de Barros, Adriana P. Do Valle, Patricia Emilia Braga, Juliana Y. K. Viscondi, Antonio R. B. da Fonseca, Tazio Vanni, Anderson da Silva, Maria Regina Cardoso, Paulo José F. Villas-Boas, Alexander Roberto Precioso

    Since the first case of COVID-19 in the world, there has been an evolution in the understanding of how the virus spreads and what must be done to contain the viral transmission at high-risk settings. Long-term care facilities (LTCFs) are considered at higher risk for virus outbreaks with poorer outcomes of residents, which can be particularly devastating in low- and middle-income countries3,4. In March 2020, the Brazilian Society of Geriatrics and Gerontology and the World Health Organization recommended the suspension of external visits to residents in LTCFs5. Therefore, the assessment of SARS CoV-2 seroprevalence is important in the definition of heath care policies in LTCFs.